title: Lipid peroxidation in hemodialysis patients: effect of vitamin C supplementation.
abstract: OBJECTIVE
  Renal failure is associated with several metabolic disturbances and increasing evidences support a role of oxidative stress and impaired antioxidant defence in the pathologic mechanisms that may contribute to accelerated atherogenesis in these patients. Aim of the study was to further investigate the relationship between oxidative stress and chronic renal failure.
  
  
  METHODS
  We compared the paraoxonase (PON1) activity, the levels of lipid hydroperoxides and AGE adducts in plasma of hemodialysis patients before and after intravenous administration of vitamin C.
  
  
  RESULTS
  An increase in lipid hydroperoxides, AGE adducts and a decrease in the activity of PON1 were observed in patients with respect to controls. The comparison before and after supplementation with vitamin C showed an increase of PON1 activity and a decrease of AGE and lipid hydroperoxides levels.
  
  
  CONCLUSIONS
  The results provide further evidence that lipid peroxidation and impairment of antioxidant system in plasma of patients may play a role in renal disease and suggest that evaluation of PON1 activity could represents an useful approach to monitor antioxidant treatment and new dialysis therapies.
authors.affiliation: Istituto di Biochimica, Università Politecnica delle Marche Via Ranieri, 60131, Ancona, Italy.
authors.forename: Gianna
authors.initials: G
authors.lastname: Ferretti
authors.forename: Tiziana
authors.initials: T
authors.lastname: Bacchetti
authors.forename: Simona
authors.initials: S
authors.lastname: Masciangelo
authors.forename: Giosafatte
authors.initials: G
authors.lastname: Pallotta
mesh_terms: D000368:Aged; D000975:Antioxidants / Q000008:administration & dosage* / Q000378:metabolism; D043303:Aryldialkylphosphatase / Q000378:metabolism; D001205:Ascorbic Acid / Q000008:administration & dosage* / Q000378:metabolism; D019587:Dietary Supplements; D005260:Female; D017127:Glycation End Products, Advanced / Q000097:blood; D006801:Humans; D007676:Kidney Failure, Chronic / Q000503:physiopathology / Q000628:therapy; D015227:Lipid Peroxidation; D008054:Lipid Peroxides / Q000097:blood; D008297:Male; D008875:Middle Aged; D018384:Oxidative Stress; D006435:Renal Dialysis / Q000009:adverse effects*
chemical_list: D000975:Antioxidants; D017127:Glycation End Products, Advanced; D008054:Lipid Peroxides; D043303:Aryldialkylphosphatase; C468406:PON1 protein, human; D001205:Ascorbic Acid